[Recurrent aseptic meningitis secondary to nonsteroidal anti-inflammatory drugs in a patient with lupus].
We report a 39-year-old woman with systemic lupus who presented with recurrent aseptic meningitis secondary to treatment with nonsteroidal anti-inflammatory drugs (NSAIDs). She presented two episodes following ibuprofen administration that were characterized by aseptic meningitis with high protein level in cerebrospinal fluid, and increased serum acute phase reactants. No evidence of an infection or vasculitis was documented. Clinical manifestation resolved rapidly with ibuprofen discontinuation, and corticosteroids therapy was unnecessary. Aseptic meningitis related to NSAIDs reported in lupus patients should be considered because of their specific modality of care and their favourable outcome.
Faurie
P
P
Service de médecine interne, hôpital Édouard-Herriot, 69003 Lyon, France.
Pérard
L
L
Hot
A
A
Desmurs-Clavel
H
H
Fassier
T
T
Boibieux
A
A
Ninet
J
J
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007052:Ibuprofen / Q000009:adverse effects*; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D008582:Meningitis, Aseptic / Q000139:chemically induced*; D012008:Recurrence
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007052:Ibuprofen